Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer

Inter-rater and intra-rater agreement of [99mTc]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer

Abstract Background Immune checkpoint inhibitors, including those against programmed cell death protein-1 (PD-1) or its ligand (PD-L1), are routinely used to treat non-small cell lung cancer (NSCLC). PD-L1 is a validated prognostic and predictive immunohistochemical biomarker of anti-PD-1/PD-L1 ther...

Full description

Bibliographic Details
Main Authors: Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, Damion Bailey, Kathryn Adamson, Vicky Goh, Gary J. R. Cook
Format: Article
Language:English
Published: SpringerOpen 2023-05-01
Series:EJNMMI Research
Subjects:
Technetium
SPECT
Non-small cell lung cancer
Immunotherapy
PD-L1
Single-domain antibody (sdAb)
Online Access:https://doi.org/10.1186/s13550-023-01002-4

Internet

https://doi.org/10.1186/s13550-023-01002-4

Similar Items